GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (NAS:TECH) » Definitions » Shiller PE Ratio

Bio-Techne (Bio-Techne) Shiller PE Ratio

: 54.14 (As of Today)
View and export this data going back to 1992. Start your Free Trial

As of today (2024-04-23), Bio-Techne's current share price is $62.80. Bio-Techne's E10 for the quarter that ended in Dec. 2023 was $1.16. Bio-Techne's Shiller PE Ratio for today is 54.14.

The historical rank and industry rank for Bio-Techne's Shiller PE Ratio or its related term are showing as below:

TECH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 24.57   Med: 52.3   Max: 151.37
Current: 54.14

During the past years, Bio-Techne's highest Shiller PE Ratio was 151.37. The lowest was 24.57. And the median was 52.30.

TECH's Shiller PE Ratio is ranked worse than
67.83% of 143 companies
in the Biotechnology industry
Industry Median: 32.61 vs TECH: 54.14

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bio-Techne's adjusted earnings per share data for the three months ended in Dec. 2023 was $0.170. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.16 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bio-Techne Shiller PE Ratio Historical Data

The historical data trend for Bio-Techne's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.72 78.24 126.98 83.19 70.94

Bio-Techne Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.42 66.43 70.94 58.30 66.62

Competitive Comparison

For the Biotechnology subindustry, Bio-Techne's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne Shiller PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Bio-Techne's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Shiller PE Ratio falls into.



Bio-Techne Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bio-Techne's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=62.80/1.16
=54.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Bio-Techne's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.17/129.4194*129.4194
=0.170

Current CPI (Dec. 2023) = 129.4194.

Bio-Techne Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.213 99.695 0.277
201406 0.180 100.560 0.232
201409 0.160 100.428 0.206
201412 0.223 99.070 0.291
201503 0.163 99.621 0.212
201506 0.178 100.684 0.229
201509 0.153 100.392 0.197
201512 0.173 99.792 0.224
201603 0.203 100.470 0.261
201606 0.173 101.688 0.220
201609 0.125 101.861 0.159
201612 0.050 101.863 0.064
201703 0.148 102.862 0.186
201706 0.193 103.349 0.242
201709 0.105 104.136 0.130
201712 0.323 104.011 0.402
201803 0.130 105.290 0.160
201806 0.268 106.317 0.326
201809 0.113 106.507 0.137
201812 0.113 105.998 0.138
201903 0.288 107.251 0.348
201906 0.105 108.070 0.126
201909 0.093 108.329 0.111
201912 0.755 108.420 0.901
202003 0.230 108.902 0.273
202006 0.370 108.767 0.440
202009 0.208 109.815 0.245
202012 0.288 109.897 0.339
202103 0.280 111.754 0.324
202106 0.093 114.631 0.105
202109 0.423 115.734 0.473
202112 0.490 117.630 0.539
202203 0.370 121.301 0.395
202206 0.378 125.017 0.391
202209 0.550 125.227 0.568
202212 0.310 125.222 0.320
202303 0.430 127.348 0.437
202306 0.470 128.729 0.473
202309 0.310 129.860 0.309
202312 0.170 129.419 0.170

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bio-Techne  (NAS:TECH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bio-Techne Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Techne (Bio-Techne) Business Description

Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Executives
Roeland Nusse director 473 TENNESSEE, PALO ALTO CA 94306
William Geist officer: PRESIDENT, PROTEIN SCIENCES 900 MIDDLESEX TURNPIKE, C/O QUANTERIX CORPORATION, BILLERICA MA 01821
Charles R. Kummeth director, officer: Chief Executive Officer 425 MARTINGALE ROAD, SUITE 1000, SCHAUMBURG IL 60173-2213
Shane Bohnen officer: SVP - General Counsel 614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
Brenda S. Furlow officer: SVP - General Counsel 614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
John L Higgins director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Robert V Baumgartner director 5775 WAYZATA BOULEVARD, SUITE 400, MINNEAPOLIS MN 55416
Kim Kelderman officer: Pres. Diagnostics & Genom 614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
Norman David Eansor officer: SVP Biotech 8100 SOUTHPARK WAY, A-8, LITTLETON CO 80120
James Hippel officer: Chief Financial Officer 614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
Joseph D Keegan director C/O MOLECULAR DEVICES CORP, 1311 ORLEANS DRIVE, SUNNYVALE CA 94089
Alpna Seth director 614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413
Julie L Bushman director 185 SOUTH 84TH STREET, SUITE 200, MILWAUKEE WI 53214
Rupert Vessey director C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901
Randolph C Steer director 614 MCKINLEY PLACE NE, MINNEAPOLIS MN 55413

Bio-Techne (Bio-Techne) Headlines